← Open Payments lookup

HILDA RAISCH: Open Payments

NPI 1376805713 · GLEN BURNIE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$173 in 9 payments from 7 companies in 2025. Trend: 2023 $1,792 · 2024 $1,855 · 2025 $173

Food & beverage: $173
CompanyPaymentsAmount
Novo Nordisk Inc2$48
ABBVIE INC.2$34
Boehringer Ingelheim Pharmaceuticals, Inc.1$22
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$18
Lilly USA, LLC1$18
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$17
Amgen Inc.1$16

Products named: VRAYLAR, Rybelsus, JARDIANCE, CAPLYTA, MOUNJARO, XIFAXAN, KRYSTEXXA.

Industry payments across MD — which companies pay providers there.